OTCMKTS:PDDPF Medexus Pharmaceuticals (PDDPF) Stock Price, News & Analysis → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free PDDPF Stock Alerts $2.14 0.00 (0.00%) (As of 08/4/2023) Add Compare Share Share Today's Range$2.11▼$2.4250-Day Range$2.14▼$2.1452-Week Range$1.70▼$3.99Volume39,966 shsAverage Volume4,355 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Medexus Pharmaceuticals alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About Medexus Pharmaceuticals Stock (OTCMKTS:PDDPF)Medexus Pharmaceuticals, Inc. operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.Read More PDDPF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDDPF Stock News HeadlinesApril 3, 2024 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc flat on Monday (MDP)January 10, 2024 | morningstar.comMedexus Pharmaceuticals Inc MEDXFMay 5, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?December 21, 2023 | morningstar.comMedexus Pharmaceuticals Inc MDPNovember 1, 2023 | msn.comMedexus Pharmaceuticals (MEDXF) Price Target Increased by 8.29% to 3.16October 18, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc flat on Tuesday (MDP)October 17, 2023 | finance.yahoo.comMedexus Announces Full Exercise and Closing of Over-Allotment Option in Bought-Deal Public OfferingOctober 13, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Wednesday (MDP-DB)May 5, 2024 | The Freeport Society (Ad)Biden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?October 11, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Friday (MDP-DB)September 6, 2023 | msn.comMedexus Pharmaceuticals announces C$10M offeringAugust 4, 2023 | finance.yahoo.comMedexus to Participate in Fireside Chat at SHARE Series EventJune 22, 2023 | markets.businessinsider.comStifel Nicolaus Upgrades Medexus Pharmaceuticals Inc (MDP) to BuyJune 20, 2023 | finance.yahoo.comMorning News Call - Canada, June 20May 16, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc down on Monday (MDP)May 10, 2023 | msn.comMedexus gets TSX nod to make NCIB for convertible debenturesMay 9, 2023 | marketwatch.comPharmaceutical Drug Delivery Market Research Findings to 2030April 22, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc down on Friday (MDP)April 11, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Monday (MDP)April 11, 2023 | marketwatch.comMedexus Pharma Names Michael Mueller Chairman, Forecasts Rise in 4Q RevenueApril 11, 2023 | msn.comMedexus expects FY23 record revenue of $107M-$108MMarch 20, 2023 | marketwatch.comDiaphragm Valves for Pharmaceutical Process Market 2023 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2029February 22, 2023 | marketwatch.comDrug and Pharmaceuticals and Cosmetics Retail Market Foreseen To Grow Exponentially Over 2023-2029February 2, 2023 | marketwatch.comAn Overview of Anti-Counterfeit Pharmaceuticals And Cosmetics Market, Major Participants, and Prospects by 2029January 31, 2023 | marketwatch.comMiddle-aged and Elderly Health Supplements Market: 2023 [Latest Report] By Top Leading Players Analysis Till 2028January 31, 2023 | marketwatch.comOral Mucositis Market with Strong Focus on Industry Size, by Financial Highlights, Market Segments, Growth Rate, Revenue, and Forecast to 2029January 30, 2023 | marketwatch.comPeptide Therapy Industry by 360 Market Updates with, New Companies, Major Strategies, Massive Strategies And Forecast 2028See More Headlines Receive PDDPF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:PDDPF CUSIPN/A CIKN/A Webwww.medexus.com Phone(514) 762-2626FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesKenneth d’EntremontChief Executive Officer & DirectorRoland BoivinChief Financial OfficerMichael PineSenior VP-Business Development & StrategyRichard LabelleVice President-Marketing & SalesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors PDDPF Stock Analysis - Frequently Asked Questions How have PDDPF shares performed in 2024? Medexus Pharmaceuticals' stock was trading at $2.14 at the beginning of the year. Since then, PDDPF shares have increased by 0.0% and is now trading at $2.14. View the best growth stocks for 2024 here. How do I buy shares of Medexus Pharmaceuticals? Shares of PDDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PDDPF) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsAutomatic Income (from home)Awesomely, LLCBiden Nomination CANCELED?The Freeport SocietyThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
